The augmentation of tumor-specific immunity with immune RNA.
D000818:Animals; D002478:Cells, Cultured; D006168:Guinea Pigs; D007111:Immunity, Cellular; D007114:Immunization; D007166:Immunosuppressive Agents / Q000494:pharmacology; D066298:In Vitro Techniques; D009052:Leukemia Virus, Murine; D008214:Lymphocytes / Q000276:immunology; D009369:Neoplasms / Q000276:immunology*; D009374:Neoplasms, Experimental; D012334:RNA, Neoplasm / Q000302:isolation & purification / Q000494:pharmacology*; D013154:Spleen; D013936:Thymidine; D014181:Transplantation Immunology; D014316:Tritium
D007166:Immunosuppressive Agents; D012334:RNA, Neoplasm; D014316:Tritium; D013936:Thymidine